Search
for
Sort by
Research 841–870 of 1000+
- Psoriasis of the Scalp
- Pharmacology of antiandrogens
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Adverse Cutaneous Reactions to Antipsychotics
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Adverse Cutaneous Reactions to Mood Stabilizers
- Regulatory T cells in inflammatory skin disease: from mice to humans
- The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches
- A hair growth questionnaire for use in the evaluation of therapeutic effects in men
- Destruction of the arrector pili muscle and fat infiltration in androgenic alopecia
- Acne in women
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Alopecia and grey hair are associated with COVID‐19 Severity
- Immune cell regulation of the hair cycle
- Clinical Approach to the Patient With Alopecia
- What is the Rationale for Androgen Therapy for Women?
- Further errors in polymorph identification: furosemide and finasteride
- Relating neurosteroid modulation of inhibitory neurotransmission to behaviour
- Phytochemical, Toxicological and Pharmacological Studies of <i>Asiasari Radix</i> et Rhizoma: A Review
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Thiolated and PEGylated silica nanoparticle delivery to hair follicles
- The triple rotation scalp flap revisited: a case of reconstruction of cicatricial pressure alopecia
- MoS2 Nanoclusters-based biomaterials for disease- impaired wound therapy
- Restoration of hair-inductive activity of cultured human follicular keratinocytes by co-culturing with dermal papilla cells
- Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice
- Ethinylestradiol/Chlormadinone Acetate
- Diseases on Hair Follicles Leading to Hair Loss Part I: Nonscarring Alopecias
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- Topical Treatments for Scalp Psoriasis
- Is there a role for 5α‐reductase inhibitors in transgender individuals?